SEC Form 4 · accession 0001567619-18-002056
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan W Ayers
Officer — Chairman, President & CEO · Director
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | G | 40,000 | $0.00 | D | 1,063,469 | D | |
| Common StockF1 | Aug 30, 2018 | G | 40,000 | $0.00 | A | 138,000 | I | by Ayers Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.